Back
IDEXX Laboratories Vs. Monopar Therapeutics Industry Stock Comparison
Sell
50
IDXX
IDEXX Laboratories
Last Price:
$417.92
Seasonality Move:
5.78%
Sell
46
MNPR
Monopar Therapeutics
Last Price:
$37.99
Seasonality Move:
-13.48%
Sell
50
IDEXX Laboratories (IDXX)
is a Sell
Is IDEXX Laboratories a Buy, Sell or Hold?
-
The current IDEXX Laboratories [IDXX] share price is $423.60. The Score for IDXX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
IDXX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Monopar Therapeutics (MNPR)
is a Sell
Is Monopar Therapeutics a Buy, Sell or Hold?
-
The current Monopar Therapeutics [MNPR] share price is $37.60. The Score for MNPR is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IDXX Stock Price Chart
What is IDEXX Laboratories's stock price today?
-
The IDEXX Laboratories share price today is $423.60Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IDXX is experiencing slight selling pressure.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $37.60The current trend is moderately bullish and MNPR is experiencing slight selling pressure.
IDXX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -6.2 | Sell |
| Relative Strength Index (14 RSI): | 44.84 | Sell |
| Chaikin Money Flow: | -241037 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (419.35 - 450.29) | Sell |
| Bollinger Bands (100): | (415.24 - 446.96) | Sell |
MNPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.33 | Buy |
| Relative Strength Index (14 RSI): | 53.16 | Buy |
| Chaikin Money Flow: | -4864 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.9 - 41.16) | Buy |
| Bollinger Bands (100): | (18.89 - 38.95) | Buy |
IDXX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 418.81 | Buy |
| 20-day SMA: | 430.67 | Sell |
| 50-day SMA: | 436.1 | Sell |
| 200-day SMA: | 458.62 | Sell |
| 8-day EMA: | 421.96 | Buy |
| 20-day EMA: | 428.11 | Sell |
| 50-day EMA: | 433.56 | Sell |
| 200-day EMA: | 454.47 | Sell |
MNPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.16 | Buy |
| 20-day SMA: | 33.55 | Buy |
| 50-day SMA: | 36.72 | Buy |
| 200-day SMA: | 16.35 | Buy |
| 8-day EMA: | 37.12 | Buy |
| 20-day EMA: | 35.96 | Buy |
| 50-day EMA: | 34.41 | Buy |
| 200-day EMA: | 21.02 | Buy |
IDEXX Laboratories Earnings Growth & IDXX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.41 per share, an increase next quarter of $0.22 per share, an increase this year of $1.28 per share, and an increase next year of $1.63 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and an increase next year of $2.24 per share.
IDEXX Laboratories Technical Analysis
| Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Monopar Therapeutics Technical Analysis
| Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||